A detailed history of Fifth Third Bancorp transactions in Abb Vie Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,619,206 shares of ABBV stock, worth $291 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
1,619,206
Previous 1,622,079 0.18%
Holding current value
$291 Million
Previous $278 Million 14.93%
% of portfolio
1.17%
Previous 1.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$163.84 - $199.33 $470,712 - $572,675
-2,873 Reduced 0.18%
1,619,206 $320 Million
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $3.79 Million - $4.42 Million
-24,463 Reduced 1.49%
1,622,079 $278 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $1.48 Million - $1.69 Million
9,254 Added 0.57%
1,646,542 $300 Million
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $4.15 Million - $4.67 Million
-30,159 Reduced 1.81%
1,637,288 $254 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $112,616 - $130,369
843 Added 0.05%
1,667,447 $249 Million
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $2.27 Million - $2.82 Million
17,130 Added 1.04%
1,666,604 $225 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $4.56 Million - $5.26 Million
-31,566 Reduced 1.88%
1,649,474 $263 Million
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $7.01 Million - $8.41 Million
50,702 Added 3.11%
1,681,040 $0
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $359,951 - $412,840
2,682 Added 0.16%
1,630,338 $219 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $5.6 Million - $7.13 Million
40,728 Added 2.57%
1,627,656 $249 Million
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $2.22 Million - $2.75 Million
-16,783 Reduced 1.05%
1,586,928 $257 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $4.72 Million - $5.97 Million
43,942 Added 2.82%
1,603,711 $217 Million
Q3 2021

Oct 15, 2021

BUY
$106.4 - $120.78 $6.97 Million - $7.92 Million
65,548 Added 4.39%
1,559,769 $168 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $6.33 Million - $7.06 Million
-60,201 Reduced 3.87%
1,494,221 $168 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $5.18 Million - $5.71 Million
50,671 Added 3.37%
1,554,422 $168 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $4.54 Million - $6.13 Million
56,448 Added 3.9%
1,503,751 $161 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $3.47 Million - $4.07 Million
40,361 Added 2.87%
1,447,303 $127 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $9.76 Million - $13.1 Million
132,957 Added 10.44%
1,406,942 $138 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $4.53 Million - $6.87 Million
70,234 Added 5.83%
1,273,985 $97.1 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $5.52 Million - $6.91 Million
76,561 Added 6.79%
1,203,751 $107 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $2.65 Million - $3.18 Million
41,999 Added 3.87%
1,127,190 $85.4 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $667,183 - $852,816
-10,155 Reduced 0.93%
1,085,191 $78.9 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $15 Million - $17.7 Million
-194,691 Reduced 15.09%
1,095,346 $88.3 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $389 - $480
-5 Reduced -0.0%
1,290,037 $119 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $11.4 Million - $12.7 Million
-128,657 Reduced 9.07%
1,290,042 $122 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $4.08 Million - $4.82 Million
45,409 Added 3.31%
1,418,699 $131 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $2.71 Million - $3.63 Million
29,441 Added 2.19%
1,373,290 $130 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $6.29 Million - $6.89 Million
-70,195 Reduced 4.96%
1,343,849 $130 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.84 Million - $2.35 Million
26,289 Added 1.89%
1,414,044 $126 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,387,755
1,387,755 $101 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.